German
€0.00*

How can the Specific Requirements for Sterile Products be Taken into Account in the Quality Management System?

  • Question of the Week

The Pharmaceutical Quality System (PQS) of a sterile manufacturer should cover the specific requirements of sterile products and thus ensure that the risk of particulate and microbial contamination (including endotoxins) is minimized.

[GMP Compliance Adviser, Chapter 12.C]

Would you like to discover more?

The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business. 

The demo access is non-binding and ends automatically.

Test it now for free

You may also be interested in the following articles:

EMA: Revised Q&A MRA EU-USA
News

EMA: Revised Q&A MRA EU-USA

The EMA has updated its Questions and Answers on the EU-US Mutual Recognition Agreement (MRA). The update follows the completion of the FDA's assessment of all EU authorities responsible for GMP inspections of veterinary medicinal products on 29 May 2026.
Read more
WHO: Draft on Regulatory Ovesight of Disposal of Medical Products
News

WHO: Draft on Regulatory Ovesight of Disposal of Medical Products

WHO published a draft consultation document on regulatory oversight of disposal of medical products throughout the lifecycle.
Read more
What are the Basic Principles of Organisational Structures?
Question of the Week

What are the Basic Principles of Organisational Structures?

Here's the answer:
Read more
Why Nobody Wants ICH Q14 — And Why That’s Exactly the Problem
LOGFILE Feature

Why Nobody Wants ICH Q14 — And Why That’s Exactly the Problem

The ICH Guideline Q14 “Analytical Procedure Development” was published in November 2023. This forward-looking and regulatory-savvy document builds upon the content of ICH Q2(R2) “Validation of Analytical Procedures” and incorporates elements from ICH Q8 “Pharmaceutical Development” and ICH Q9(R1) “Quality Risk Management.”
Read more
EU: GMP Annex 19 Updated
News

EU: GMP Annex 19 Updated

The European Commission has published a revised version of Annex 19 “Reference and Retention Samples”. The update mainly affects requirements for reference and retention samples of parallel imported, parallel distributed and parallel traded medicinal products.
Read more
ANVISA: Expands Recognition of Foreign GMP Authorities
News

ANVISA: Expands Recognition of Foreign GMP Authorities

Brazilian health authority ANVISA has updated the requirements for the recognition of Equivalent Foreign Regulatory Authorities (AREE) and the administrative procedures for Good Manufacturing Practice (GMP) certification (CBPF) through Normative Instruction IN 451/2026. The aim is to streamline and accelerate regulatory processes.
Read more
Previous
Next
This website uses cookies to ensure the best experience possible. More information...